At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Invia Motiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medela INVIA Motion NPWT System for Prophylactic Use on Surgical Incision After Cesarean Delivery
In Brief
A Phase 4 clinical trial evaluating Invia Motion for Negative Pressure Wound Therapy and Cesarean Section; Infection. Completed, enrolled 20 participants across 1 site.
Detailed Summary
To assess patient centered outcomes of the Medela INVIA Motion prophylactic NPWT system at cesarean delivery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMedela AG
Timeline
Phase 4CompletedFinished
202120222023202420252026
Enrollment StartMar 2020
First PostedApr 2020
Primary CompletionAug 2020
Study CompletionDec 2020
TodayJul 2026
First PostedApr 28, 2020
Enrollment StartMar 10, 2020
Primary CompletionAug 31, 2020
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.2 years ago
Interventions
Invia Motiondevice
Invia Motion NPWT system at cesarean delivery